Key Events This Week
9 Mar: Technical momentum shifts amid mixed market signals and valuation reclassification
10 Mar: Technical momentum turns more bearish with increased downside pressure
13 Mar: Week closes with a 5.03% decline, underperforming the Sensex

Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals
2026-03-10 08:01:12Hester Biosciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest recovery in the past year, the stock’s recent price action and technical parameters suggest caution for investors amid weakening momentum and persistent downward pressures.
Read full news article
Hester Biosciences Ltd is Rated Sell
2026-03-09 10:10:02Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-03-09 08:00:29Hester Biosciences Ltd has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock exhibits mixed signals across key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment in the Pharmaceuticals & Biotechnology sector.
Read full news article
Hester Biosciences Ltd Valuation Shifts Signal Price Attractiveness Amid Sector Challenges
2026-03-09 08:00:17Hester Biosciences Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a subtle but meaningful change in price attractiveness. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the company’s valuation metrics such as P/E and P/BV ratios suggest a nuanced repositioning relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.
Read full news article
Hester Biosciences Ltd is Rated Sell
2026-03-08 10:10:03Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article








